INOGEN INC (INGN) Stock News
NASDAQ:INGN - Nasdaq - US45780L1044 - Common Stock - Currency: USD
INGN Latest News, Press Relases and Analysis
Here's Why You Should Add Inogen Stock to Your Portfolio Now
Expanding product portfolio and high prospects for POC raise optimism for INGN stock.
Zacks.com featured highlights Urban Outfitters, Inogen and Southwest Gas
Urban Outfitters, Inogen and Southwest Gas see rising broker confidence with earnings growth forecasts and notable rating upgrades.
The Best Time To Buy a Stock, According to ‘Rich Dad’ Robert Kiyosaki
It can be overwhelming to decide when, or if, you should buy into the stock market. Find out what "Rich Dad" Robert Kiyosaki says and learn when to invest.
3 Stocks With Upgraded Broker Ratings to Bet on Amid Uncertainties
Broker upgrades boost URBN, INGN and SWX, with earnings growth and strong Zacks Ranks signaling potential upside despite market volatility.
Why AI Stock Applied Digital Stock Surged More Than 10% Higher Today
Applied Digital (NASDAQ: APLD) was a double-digit winner on Thursday, as its stock price popped by over 10%. Applied's share price trajectory was all the more impressive, considering that the S&P 500 index basically closed flat across the trading session. The initiating party was Citizens JMP's Greg Miller, who launched his tracking of Applied stock by tagging it with a market outperform (read: buy) recommendation at a price target of $12 per share.
Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough
Needham's Mike Matson upgrades Inogen to Buy, citing turnaround progress, margin gains, and path to EBITDA breakeven by 2025.
What Makes Inogen (INGN) a New Buy Stock
Inogen (INGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Light & Wonder (LNW) Reaffirms FY25 EBITDA Target of $1.4 Billion, Eyes Gaming Expansion
Light & Wonder, Inc. (NASDAQ:LNW) has reaffirmed its FY2025 EBITDA target of $1.4 billion as it plans to expand the gaming segment in North America. The company reported key strategic decisions and financial targets for FY25, highlighted during its investor day on May 20 in New York City. The company is focusing on expansion in […]
Was Jim Cramer Right About Nutanix, Inc. (NTNX)?
We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at where Nutanix, Inc. (NASDAQ:NTNX) stands against other stocks that Jim Cramer discusses. Back in 2024, on May 217, a caller asked if Nutanix, Inc. (NASDAQ:NTNX) had more room to run […]
Sidus Space (SIDU) Launches Fortis VPX an AI Enabled Module Enabling Complex Missions
On May 22, Sidus Space, Inc. (NASDAQ:SIDU) announced the launch of its Fortis VPX, a modular computing system. This ruggedized system is designed for high-reliability command and data handling, and advanced AI/ML processing, and will enable precision navigation in extreme conditions. The new Fortis VPX follows the Sensor Open Systems Architecture (SOSA) and also uses […]
Inogen (INGN) Down 11.6% Since Last Earnings Report: Can It Rebound?
Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Needham Upgrades Inogen (INGN) to Buy
On May 22, Needham analysts upped Inogen, Inc. (NASDAQ:INGN)’s stock from “Hold” to “Buy”, offering a price objective of $12.00. The upgrade stems from the belief that the company’s efforts under new management are not being given due weightage. Inogen, Inc. (NASDAQ:INGN), a medical technology company, has exhibited a return to positive mid-single-digit revenue growth. […]
BayCom Corp (BCML) Announces a Significant 33% Dividend Hike for Shareholders
On May 21, BayCom Corp (NASDAQ:BCML) declared a 33% hike in its quarterly dividend to $0.20 per share. BayCom Corp (NASDAQ:BCML), operating through its fully owned subsidiary United Business Bank, provides a wide variety of loan options—including SBA, CalCAP, FSA, and USDA-backed loans—alongside deposit products and services to businesses and their affiliates across California, Nevada, […]
After Plunging -15.69% in 4 Weeks, Here's Why the Trend Might Reverse for Inogen (INGN)
Inogen (INGN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
INGN Stock Gains Following Q1 Earnings Beat, Revenues Up Y/Y
Inogen's overall first-quarter 2025 results continue to gain from higher business-to-business sales.
Here's What Key Metrics Tell Us About Inogen (INGN) Q1 Earnings
Although the revenue and EPS for Inogen (INGN) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Inogen (INGN) Reports Q1 Loss, Tops Revenue Estimates
Inogen (INGN) delivered earnings and revenue surprises of 51.92% and 3.26%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: MASS
Inogen Announces First Quarter 2025 Financial Results
MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN
The medical device industry is growing fast in 2025, but faces supply and trade issues. Major companies are set to report earnings on May 7, stay tuned!
Mettler-Toledo (MTD) Q1 Earnings and Revenues Beat Estimates
Mettler-Toledo (MTD) delivered earnings and revenue surprises of 3.67% and 1%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: MTD
Inogen to Report First Quarter 2025 Financial Results on May 7, 2025
Inogen To Present at 24th Annual Needham Virtual Healthcare Conference
Inogen Announces Fourth Quarter and Full Year 2024 Financial Results
Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device
Inogen Announces Third Quarter 2024 Financial Results
Inogen to Present at Upcoming Investor Conferences
